Kazuhiko Kido

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Pulmonary Arterial Hypertension

Ejection Fraction

Top Venues

The Annals of pharmacotherapy

Journal of pharmacy practice

Pharmacotherapy

Journal of cardiovascular pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan W Bok, Jordan L Lacoste, Wei Fang, Kazuhiko Kido
Impact of Outpatient Beta Blocker Therapy Adjustment on Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction Admitted for Acute Decompensated Heart Failure. Journal of pharmacy practice (2024)
Kazuhiko Kido, Christopher Bianco, Marco Caccamo, Masayuki Hashiguchi, Lyn Yuen Choo, George Sokos
Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction. Journal of pharmacy practice (2023)
Kazuhiko Kido, Bailey M Colvin, Rachael Broscious, Sydney Bongiorni, George Sokos, Khalid M Kamal
Economic Impact of Ambulatory Clinical Pharmacists in an Advanced Heart Failure Clinic. The Annals of pharmacotherapy (2022)
Kazuhiko Kido, Galen M Kabulski, Thomas W Szymanski, Tsuyoshi Shiga, Mikiko Shimizu, Masayuki Hashiguchi
Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane Oxygenation. Journal of pharmacy practice (2022)
Kazuhiko Kido, Yasir Abdul Ghaffar, James C Lee, Christopher Bianco, Mikiko Shimizu, Tsuyoshi Shiga, Masayuki Hashiguchi
Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PloS one 16 (6) (2021)
Kazuhiko Kido, Christopher Bianco, Marco Caccamo, Wei Fang, George Sokos
Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan. Journal of cardiovascular pharmacology and therapeutics 26 (6) (2021)
Hannah Brokmeier, Kazuhiko Kido
Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review. The Annals of pharmacotherapy 55 (8) (2020)
Kazuhiko Kido, Christopher Bianco, Marco Caccamo, Wei Fang, George Sokos
Evaluating Sacubitril/Valsartan Dose Dependence on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. The Annals of pharmacotherapy 55 (9) (2020)
Kazuhiko Kido, James C Lee, Thaddaus Hellwig, Michael P Gulseth
Use of Direct Oral Anticoagulants in Morbidly Obese Patients. Pharmacotherapy 40 (1) (2019)
Kazuhiko Kido, James C Coons
Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review. Pharmacotherapy 39 (9) (2019)